These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4861752)

  • 1. Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
    Goldberg SC; Schooler NR; Mattsson N
    J Nerv Ment Dis; 1967 Aug; 145(2):158-62. PubMed ID: 4861752
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

  • 3. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of improvement in schizophrenia under four phenothiazines.
    Goldberg SC; Mattsson N; Cole JO; Klerman GL
    Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differential indication for the use of neuroleptics].
    Vinar O
    Act Nerv Super (Praha); 1970 Jan; 12(1):1-11. PubMed ID: 4907389
    [No Abstract]   [Full Text] [Related]  

  • 6. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
    Schooler NR; Boothe H; Goldberg SC
    Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 8. The comparative effectiveness of eight phenothiazines.
    Hanlon TE; Michaux MH; Ota KY; Shaffer JW; Kurland AA
    Psychopharmacologia; 1965 Feb; 7(2):89-106. PubMed ID: 5318926
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

  • 11. Temporal changes in handwriting size, level of premorbid social functioning and intellectural level during treatment in acute schizophrenics.
    Downing RW; Ebert JN; Boruchow JK; Valentine JH
    J Nerv Ment Dis; 1966 Jun; 142(6):526-33. PubMed ID: 5920205
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyskinesia and neuroleptics.
    Crane GE
    Arch Gen Psychiatry; 1968 Dec; 19(6):700-3. PubMed ID: 5697636
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of disorders of character and schizophrenia by pericyazine (Neulactil).
    Rasch PJ
    Acta Psychiatr Scand Suppl; 1966; 191():200-15. PubMed ID: 5336387
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 18. PHENOTHIAZINE REDUCTION AS A CAUSE OF REHOSPITALIZATION.
    GANTZ RS; BIRKETT DP
    Arch Gen Psychiatry; 1965 Jun; 12():586-8. PubMed ID: 14286887
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of chlorpromazine and fluphenazine on some schizophrenic forms of behaviour.
    Jovanović T; Marković A
    Br J Psychiatry; 1972 Feb; 120(555):223-4. PubMed ID: 5043728
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of haloperidol in drug refractory patients.
    Ban TA; Lehmann HE
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:78-86. PubMed ID: 4383142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.